ICYMI 2021 Rheumatology Year in Review

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications3.  New Biologics for Lupus4. Super "H" Hydroxychloroquine5. Zoomatology6. Avacopan7. Tocilizumab8. FDA & JAK inhibitor warnings9. New Biologics for GCA10. IL-23 Inhibitors https://rheumnow.com/news/2021-rheumatology-year-review-172022